Jialiang Luo

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 15

Top Topics

Combination Therapy

Atopic Dermatitis

Inflammatory Response

Top Venues

Molecular medicine (Cambridge, Mass.)

Mediators of inflammation

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Jialiang Luo, Zhengyumeng Zhu, Yumeng Zhai, Junxiang Zeng, Lei Li, Di Wang, Fan Deng, Bo Chang, Jia Zhou, Ledong Sun
The Role of TSLP in Atopic Dermatitis: From Pathogenetic Molecule to Therapeutical Target. Mediators of inflammation 2023 (2023)
Jialiang Luo, Kaifeng Mao, Zhengyumeng Zhu, Junli Ye, Lei Li, Di Wang, Jia Zhou, Fenwang Lin, Juan Li, Junsheng Ye
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jialiang Luo, Zhengyumeng Zhu, Yumeng Zhai, Junxiang Zeng, Lei Li, Di Wang, Fan Deng, Bo Chang, Jia Zhou, Ledong Sun
The Role of TSLP in Atopic Dermatitis: From Pathogenetic Molecule to Therapeutical Target. Mediators of inflammation 2023 (2023)
Jialiang Luo, Zhengyumeng Zhu, Yumeng Zhai, Junxiang Zeng, Lei Li, Di Wang, Fan Deng, Bo Chang, Jia Zhou, Ledong Sun
The Role of TSLP in Atopic Dermatitis: From Pathogenetic Molecule to Therapeutical Target. Mediators of inflammation 2023 (2023)
Jialiang Luo, Kaifeng Mao, Zhengyumeng Zhu, Junli Ye, Lei Li, Di Wang, Jia Zhou, Fenwang Lin, Juan Li, Junsheng Ye
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jialiang Luo, Kaifeng Mao, Zhengyumeng Zhu, Junli Ye, Lei Li, Di Wang, Jia Zhou, Fenwang Lin, Juan Li, Junsheng Ye
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jialiang Luo, Kaifeng Mao, Zhengyumeng Zhu, Junli Ye, Lei Li, Di Wang, Jia Zhou, Fenwang Lin, Juan Li, Junsheng Ye
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jialiang Luo, Zhengyumeng Zhu, Yumeng Zhai, Junxiang Zeng, Lei Li, Di Wang, Fan Deng, Bo Chang, Jia Zhou, Ledong Sun
The Role of TSLP in Atopic Dermatitis: From Pathogenetic Molecule to Therapeutical Target. Mediators of inflammation 2023 (2023)
Jialiang Luo, Kaifeng Mao, Zhengyumeng Zhu, Junli Ye, Lei Li, Di Wang, Jia Zhou, Fenwang Lin, Juan Li, Junsheng Ye
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jialiang Luo, Kaifeng Mao, Zhengyumeng Zhu, Junli Ye, Lei Li, Di Wang, Jia Zhou, Fenwang Lin, Juan Li, Junsheng Ye
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jialiang Luo, Zhengyumeng Zhu, Yumeng Zhai, Junxiang Zeng, Lei Li, Di Wang, Fan Deng, Bo Chang, Jia Zhou, Ledong Sun
The Role of TSLP in Atopic Dermatitis: From Pathogenetic Molecule to Therapeutical Target. Mediators of inflammation 2023 (2023)
Jialiang Luo, Kaifeng Mao, Zhengyumeng Zhu, Junli Ye, Lei Li, Di Wang, Jia Zhou, Fenwang Lin, Juan Li, Junsheng Ye
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jialiang Luo, Kaifeng Mao, Zhengyumeng Zhu, Junli Ye, Lei Li, Di Wang, Jia Zhou, Fenwang Lin, Juan Li, Junsheng Ye
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jialiang Luo, Kaifeng Mao, Zhengyumeng Zhu, Junli Ye, Lei Li, Di Wang, Jia Zhou, Fenwang Lin, Juan Li, Junsheng Ye
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jun Cao, Lijun Dong, Jialiang Luo, Fanning Zeng, Zexuan Hong, Yunzhi Liu, YiBo Zhao, Zheng-Yuan Xia, Daming Zuo, Li Xu, Tao Tao
Supplemental N-3 Polyunsaturated Fatty Acids Limit A1-Specific Astrocyte Polarization via Attenuating Mitochondrial Dysfunction in Ischemic Stroke in Mice. Oxidative medicine and cellular longevity 2021 (2021)